Trials / Completed
CompletedNCT03759743
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
a Randomised, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | LMT1-48 | capsules containing Probiotics |
| DIETARY_SUPPLEMENT | Placebo | capsules that did not contain any probiotics |
Timeline
- Start date
- 2018-09-04
- Primary completion
- 2019-08-17
- Completion
- 2020-01-07
- First posted
- 2018-11-30
- Last updated
- 2020-07-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03759743. Inclusion in this directory is not an endorsement.